Exchange: NASDAQ·Updated 04:17 AM EDT
ACRS logo

ACRSAclaris Therapeutics Inc

$5.79
$0.50
(9.45%)
Pre-Market
Prev Close $5.29
EarningsAug 6
Mkt Cap$701.11M
Vol1,194.00

About

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
73

Frequently Asked Questions

What is Market Cap of Aclaris Therapeutics Inc?
What is the 52-week high for Aclaris Therapeutics Inc?
What is the 52-week low for Aclaris Therapeutics Inc?
What is Aclaris Therapeutics Inc stock price today?
What was Aclaris Therapeutics Inc stock price yesterday?
What is the PE ratio of Aclaris Therapeutics Inc?
What is the Price-to-Book ratio of Aclaris Therapeutics Inc?
What is the 50-day moving average of Aclaris Therapeutics Inc?
How many employees does Aclaris Therapeutics Inc have?

Advertisement|Remove ads.